Related Experiment Videos
Tinnitus improvement with ultra-high-frequency vibration therapy
Barbara A Goldstein1, Martin L Lenhardt, Abraham Shulman
1Department of Otolaryngology, State University of New York, Downstate Medical Center, Brooklyn, New York 11203, USA. metrc@inch.com
The International Tinnitus Journal
|January 20, 2006
Summary
Ultra-high-frequency masking using the UltraQuiet device offers long-term benefits for tinnitus relief. This high-frequency bone conduction therapy showed positive results in most patients, improving tinnitus loudness and severity.
Area of Science:
- Audiology
- Otolaryngology
- Biomedical Engineering
Background:
- Tinnitus is a common auditory condition affecting millions globally.
- Current tinnitus treatments have varying degrees of effectiveness.
- High-frequency bone conduction therapy presents a novel approach to tinnitus management.
Purpose of the Study:
- To evaluate the long-term efficacy of the UltraQuiet device for tinnitus treatment.
- To assess the impact of ultra-high-frequency masking on patient-reported outcomes and audiological measures.
- To explore the potential of high-frequency vibration as a therapeutic modality for tinnitus.
Main Methods:
- A randomized study involving 15 patients with problematic tinnitus.
- Implementation of modified medical-audiological tinnitus patient protocols with the UltraQuiet device.
- Assessment using patient questionnaires (effectiveness, loudness, severity, annoyance) and audiological tests (audiometry, masking levels, pitch/loudness matching, residual inhibition).
Main Results:
- All participants demonstrated some long-term improvements.
- A majority of patients experienced relief in at least one measured parameter.
- Positive trends were observed in subjective and objective measures of tinnitus reduction.
Conclusions:
- Ultra-high-frequency masking with the UltraQuiet device shows promise for long-term tinnitus relief.
- High-frequency bone conduction therapy is a viable option for managing tinnitus symptoms.
- Further research is warranted to optimize protocols and confirm findings in larger cohorts.